Elevated plasma homocysteine (tHcy) is considered as a risk factor for cardiovascular events, and has been associated with arterial stiffness and subclinical atherosclerosis in subjects with classical cardiovascular risk factors. The aim of this study is to investigate the association of plasma tHcy with functional and structural changes in the large arteries by measuring aortic pulsewave velocity (PWV) and carotid artery intima-media thickness (CIMT). In a population-based sample of 376 middle-aged and elderly men, tHcy levels were measured by using fluorescence polarization immunoassay. Aortic stiffness was assessed non-invasively by measuring carotid-femoral PWV with the use of applanation tonometry. CIMT was measured by ultrasonography. We used multivariate linear regression analysis with the logtransformed value of tHcy as the determinant, and aortic PWV and CIMT as outcomes. In the univariate model, PWV increased with increasing tHcy concentration; PWV increased by 2.64 m/s (95% confidence interval (CI) 1.74; 3.54) per unit change in log tHcy. After adjustment for confounders, no statistically significant association remained; PWV increased by 0.42 m/s (95% CI À0.27; 1.11) per unit change in log tHcy. Furthermore, in the univariate model, CIMT increased significantly with increasing tHcy concentration; CIMT increased by 0.19 mm (95% CI 0.11; 0.26) per unit increase log tHcy. This association was attenuated and did not remain significant after additional adjustment for age and cardiovascular confounders (b ¼ 0.06 (95% CI À0.01; 0.13)). The results of this study do not support the presence of an independent relationship between circulating tHcy levels and large artery stiffness and thickness.
Introduction
Pulse-wave velocity (PWV), a surrogate measure of arterial stiffness, has been shown to be predictive of future cardiovascular events. [1] [2] Arterial stiffness may act either as a marker for the cumulative exposure to the elevated levels of other cardiovascular risk factors, or may be directly involved in the pathophysiology of cardiovascular disease. Furthermore, carotid intimamedia thickness (CIMT) is a good marker of early atherosclerotic changes, 3 and it is also a good predictor for future cardiovascular disease (CVD). 4 There is evidence showing that elevated homocysteine (tHcy) concentrations are a major risk factor for CVD, 5, 6 although the etiological meaning of this finding is less clear, since recent studies indicate that lowering tHcy levels does not decrease CVD risk. [7] [8] [9] There are several mechanisms through which elevated tHcy may play a role in arterial disease, and one of these might be a deleterious effect of tHcy on vascular function. Elevated tHcy levels may result in vascular changes through induction of endothelial dysfunction, 10 arterial wall structural change and arterial stiffness, 11 but these associations were mostly found in persons with existing disease, familial risk, or other risk factors. However, in the general population findings are still inconclusive. [12] [13] [14] Atherosclerosis may be another pathway by which tHcy is linked with arterial disease. In general, the evidence of a relationship between tHcy levels and CIMT as a measure of generalized atherosclerosis varies, with some studies reporting this association [15] [16] [17] [18] while others do not. 12, 14, [19] [20] [21] To gain more insight into the association of circulating tHcy with PWV and CIMT, we studied their associations in a population-based sample of 376 men.
Subjects and methods

Subjects
Our study population consisted of a cohort of 400 men, aged from 40 to 80 years and who were healthy enough to visit our study centre at time of enrolment. Subjects were recruited from two sources. First, the male partners of 770 randomly selected female participants in a previous study conducted by the Julius Center were invited to participate. A total of 240 (31%) men agreed to participate. Then 1230 men were randomly selected from the municipal register of Utrecht, a town in the central Netherlands. Of this group 390 men were willing to participate (32%). A total of 16 subjects were excluded because they were not physically or mentally able to visit the study centre. Of the remaining 614 men, 400 were randomly selected to participate in the study, with equal numbers in each age decade across a range of 40-80 years. Participants visited the research centre two times. Fasting venous blood samples were taken between 0800 and 1000 hours and platelet-free serum was obtained by centrifugation. The serum immediately stored at À201C and within a week moved to À801C. The study was approved by the Institutional Review Board of the University Medical Center, Utrecht, and written informed consent was obtained from all participants.
Aortic stiffness measurement
For the PWV measurement, participants were asked to lie down for 10 min before the procedure and to refrain from talking while it was being carried out. The PWV was determined by using a SphygmoCor device (PWV Medical, Sydney, Australia), which allowed an online pulse wave recording and automatic calculation of PWV. Two transducers (Millar SPT 301 pressure transducer; Millar Instruments, Sydney, Australia) were used, one positioned at the base or the neck over the common carotid artery and the other over the femoral artery. An average of 10 successive waveforms was used in the analyses to cover a complete respiratory cycle. The whole procedure was repeated three times per subject and the average PWV value was used for the analysis. Aortic stiffness was measured in 378 subjects, using carotid-femoral PWV. Missing information was entirely due to logistical reasons. Two extreme values in PWV (2.75 and 30.51 m/s) have been excluded, since they were considered biologically implausible.
To evaluate the reproducibility of the technique in our laboratory, a subset of 20 participants had their PWV re-measured several weeks after their first visit. The mean difference in PWV of these repeat measurements was 0.09 m/s (s.d., 1.5). The intraclass correlation coefficient was 85%, indicating that 85% of the variance in the PWV measurements was due to patient differences, whereas 15% could be attributed to inter-visit differences (measurement error and intra-individual variability).
CIMT measurement
CIMT was used to assess the extent of subclinical atherosclerosis. Ultrasonography of both the left and right common carotid arteries was performed using a 7.5 MHz linear array transducer (Acuson Aspen, CO, USA). The media-adventitia interfaces of the near and the far wall of the distal common carotid artery were recorded at four predefined angles per side (180, 150, 120 and 901 for the right carotid artery and 180, 210, 240, and 2701 for the left carotid artery) using Meijer's arc. The average of the intima-media thickness of the eight predefined angles was used for each subject as a measure for wall thickness of the common carotid artery.
Reproducibility of the CIMT measurement was assessed by another sonographer scanning 21 subjects on a second occasion. Absolute mean difference (s.e.) of the repeated measurements between visits was 0.012 mm (0.004) for mean intima media thickness (IMT) of both carotid arteries. The ICC was 0.84.
Homocysteine assessment tHcy was measured using a fluorescence polarization immunoassay on an IMx analyzer (Abbott B.V., Hoofddorp, The Netherlands). The lower limit of detection was 0.5 mmol/l and inter-assay variation was 3.9, 4.2 and 3.9% at 9.9, 18.1 and 41.0 mmol/l, respectively (N ¼ 73).
Other measurements
A medical doctor obtained information on prevalent diseases, medication use, and lifestyle factors by specified medical history taking. Participants were asked about current use of medications and their replies were verified by examining labels of drugs they brought to the clinic. Smoking was estimated from self-report and participants' smoking status categorized as current, former and never. Height and weight were measured in a standing position without shoes. Waist-to-hip ratio was calculated by dividing waist circumference by hip circumference. Peripheral blood pressure was measured two times in the right brachial artery with a semiautomated device (Dynamap; Critcon Inc., Tampa, FL, USA). The average of systolic blood pressure (SBP) and diastolic blood pressure (DBP) measurements was used for analysis and further calculation. The mean arterial blood pressure (MAP) was calculated as
A venapuncture was performed between 0800 and 1000 hours, after an overnight fast and platelet free serum was obtained. Fasting glucose levels were assessed using a GlucoTouch reflectometer (lifeScan Inc., Benelux), a reagent strip glucose oxidase method. The Jaffe rate method was used to measure serum creatinine (Synchron LXi 725, Beckman Coulter Inc., CA, USA). Creatinine clearance was calculated from serum creatinine, age, and body weight according to the Cockcroft-Gault formula (140Àage (year) Â weight (kg) Â constant/serum creatinine (mmol/l)). An automatic enzymatic procedure was used to determine serum total cholesterol (Synchron LX Systems; Beckman Coulter Inc., CA, USA). Triglycerides were measured similarly.
Diabetes mellitus was defined as treatment with insulin or oral hypoglycaemic agents or fasting plasma venous glucose46.9 mmol/l. Hypertension was defined as SBPX140 mm Hg and/or DBPX90 mm Hg and/or use of antihypertensive medication. Presence of CVD was defined as coronary heart disease, peripheral artery disease or stroke.
Data analysis
In the 376 subjects included in our study, we examined the normality assumptions for the variables using the Kolmogorov-Smirnov test. To evaluate differences in means of continuous variables between quartiles of tHcy we used one-way analysis of variance or Kruskal-Wallis tests, according to the distributions of variables. Differences in proportions were tested using w 2 statistics. The distribution of tHcy was skewed, and hence we log-transformed this variable. For better understanding of the relationship between log tHcy, PWV, CIMT and other risk factors, we used Pearson correlation coefficients. Multivariate linear regression analyses were used to assess the relation of log-transformed value of tHcy as determinant and aortic PWV and CIMT as outcomes. Results were described as the linear regression coefficient (b) and the 95% confidence interval (CI). Univariate analyses (model I) were performed to identify the crude association of tHcy with PWV and CIMT. Model II included age. An additional model (III) was used that included MAP, waist-to-hip ratio, antihypertensive medication (yes/no), diabetes mellitus (yes/no), smoking status (current, former and never), and creatinine clearance. Since MAP was relatively constant along the arterial tree, we decided to adjust for this variable. Furthermore, for the analysis on tHcy and CIMT, we additionally adjusted for waist-to-hip ratio, SBP, DBP, diabetes mellitus (yes/no), smoking status (current, former and never), creatinine clearance and antihypertensive medication use. As no statistically significant associations were observed for other risk factors in our data, therefore, adjustment for them were redundant. Data analyses were performed using SPSS statistical software (version 12.0; SPSS, Chicago, IL, USA).
Results
Characteristics of the population as a whole and also distributed over quartiles of tHcy are presented in Table 1 . The 376 men in this study had a mean age of 60, and their median tHcy level was 12.5 mmol/l (interquartile range, 9.4-17.9 mmol/l). Men with There was a positive correlation between log tHcy and PWV (r ¼ 0.47, Po0.001) and between log tHcy and CIMT (r ¼ 0.24, Po0.001) (Figure 1 ). In addition, we found that age, SBP, DBP, MAP, heart rate, smoking, creatinine clearance and waist-to-hip ratio were significantly correlated with tHcy, PWV and CIMT (Table 2 ). In the unadjusted model, PWV increased significantly by 2.64 m/s (95% CI 1.74; 3.54) per unit change in log tHcy. Adjusted for age, the estimated effect was attenuated by about 60%, but remained statistically significant; PWV increased by 0.97 m/s (95% CI 0.20; 1.74) per unit change in log tHcy. Adjusted for other confounders (model III), no statistically significant association between tHcy concentration and PWV was observed; PWV increased by 0.42 m/s (95% CI À0.27; 1.11) per unit change in log tHcy. In the unadjusted model, CIMT increased significantly by 0.19 mm (95% CI 0.11; 0.26) per unit change in log tHcy. This association was attenuated and did not remain significant after adjustment for age; CIMT increase was 0.06 mm (95% CI À0.01; 0.13) per unit increase log tHcy. Further adjustment for confounders did not change the strength and significance of the association (b ¼ 0.06 (95% CI À0.01; 0.13)) ( Table 3 ).
Discussion
Our findings in this population-based study do not support the presence of an independent association between circulating tHcy levels with large artery stiffness and thickness.
Some aspects of this study need to be discussed when interpreting our findings. We used carotidfemoral PWV and CIMT as surrogate measures for structural and functional abnormality of the arterial wall as they have shown to be valid and reproducible methods that are simple and non-invasive. 22, 23 A major concern in studies that relate the biomarkers to disease is confounding by a third variable through unknown mechanisms. Consistent with previous evidence, our finding showed that most of the established cardiovascular risk factors are determinants of aortic PWV and CIMT. 24, 25 In our study, tHcy concentration was associated with PWV and CIMT in crude analyses but not after adjustment for major risk factors of vascular disease. In the analyses, we controlled for the confounding effect by a range of variables that were judged to be associated with the prognosis, such as serum cholesterol (total, high-density lipoprotein, lowdensity lipoprotein and triglycerides) levels, body mass index. As no confounding effects were observed in our data, adjusting for them was considered to be redundant. Of particular note is the observation that aortic stiffness and atherosclerosis are significantly correlated with kidney function, 21, 26 and impaired renal function is known to be causally related to raised tHcy concentrations. For this reason, we included creatinine clearance in the multivariate analyses to control for the confounding effect of renal function.
Our results are in line with previous studies in the general population that reported no association between PWV and tHcy levels. 12, 14 The fact that other studies observed a significant association between tHcy levels and PWV is probably due to the fact that those studies were performed in subjects who were at a markedly increased risk of cardiovascular events. 11, 27, 28 Two other studies reported that acute rises in tHcy after oral methionine caused increased aortic stiffness. 29, 30 We believe that this finding does not conflict with our results as these effects of tHcy were attained at concentrations that are not comparable to the epidemiological observations. Moreover, the finding was not reproduced in another study. 31 With respect to CIMT, in 2004, a meta-analysis of 54 studies concluded that observational studies generally failed to demonstrate a relationship between tHcy and CIMT in subjects with homocystinuria, uremia, hypercholesterolemia or non-insulindependent diabetes mellitus or in subjects with insulin insensitivity. 32 Weak associations, but usually only in certain subpopulations, were found in vascular disease patients and in population-based studies. [15] [16] [17] [33] [34] [35] [36] In our study, we found a borderline statistically significant effect of log tHcy levels on CIMT, so they are still in line with a small effect.
A potential explanation for our finding could be that the presence of other cardiovascular risk factors or a more advanced stage of atherosclerotic arterial disease may make the arterial wall, in particular the endothelium, more susceptible to the deleterious effect of high tHcy. Therefore, risk factors associated with conditions that are related to arterial functional and structural changes may mask a weaker association of tHcy with PWV and CIMT. Alternatively, it is possible that tHcy has no direct effect on the arteries and rather is an 'innocent bystander' in the presence of other risk factors such as raised lipid levels or impaired kidney function. 21 Reinforcing this possibility, some recent large-scale studies on reducing tHcy by increasing folate intake, have failed to show any impact of this intervention on CVD risk. [7] [8] [9] However, renal function did not modify the association of tHcy with PWV or CIMT in our data.
Another possible explanation is that low concentrations of folate, and not high tHcy, are associated Abbreviations: CIMT, carotid artery intima-media thickness; PWV, pulse-wave velocity. I Crude model. II adjusted for age. III adjusted for age, mean arterial pressure, heart rate, waist-to-hip ratio, antihypertensive medication (yes/no), diabetes mellitus (yes/ no), smoking status (current, former and never) and creatinine clearance. III* adjusted for waist-to-hip ratio, systolic blood pressure, diastolic blood pressure, diabetes mellitus (yes/no), smoking status (current, former and never), creatinine clearance and antihypertensive medication use.
with PWV and CIMT. However, the effect of low folate concentration on arterial stiffness is not clear. Only a few studies have examined whether folic acid supplementation can change vascular function. Two placebo-controlled, randomized clinical trials have shown that common carotid arterial stiffness was not altered in subjects with renal disease or in healthy individuals after long-term folic acid consumption. 37, 38 However, Williams et al. 39 observed a significant effect of short-term folic acid treatment on arterial stiffness in a small group of young men. Moreover, the results of a recent study in 819 subjects showed that CIMT was associated with low folate, but not with high tHcy. 40 As the final explanation, it is possible that an elevated tHcy concentration is related more to thrombosis than to atherosclerosis. The results of studies reporting a strong association between tHcy and cardiovascular events in high-risk subjects might indicate that tHcy-induced thrombosis is the important trigger factor for vascular occlusion. Yet there are some clinical trials that have shown that the reduction of tHcy concentrations, consequent to vitamin B supplementation decreases CIMT. 41, 42 In summary, the results of this study in a population-based sample of middle-aged and elderly men do not support the presence of an independent effect of mild elevation in tHcy levels on large artery stiffness and thickness.
